BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30141896)

  • 1. Enhanced Cancer Vaccination by In Situ Nanomicelle-Generating Dissolving Microneedles.
    Kim NW; Kim SY; Lee JE; Yin Y; Lee JH; Lim SY; Kim ES; Duong HTT; Kim HK; Kim S; Kim JE; Lee DS; Kim J; Lee MS; Lim YT; Jeong JH
    ACS Nano; 2018 Oct; 12(10):9702-9713. PubMed ID: 30141896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy.
    Duong HTT; Yin Y; Thambi T; Nguyen TL; Giang Phan VH; Lee MS; Lee JE; Kim J; Jeong JH; Lee DS
    Biomaterials; 2018 Dec; 185():13-24. PubMed ID: 30216806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-in-Oil Peptide Nanocarriers for Transcutaneous Cancer Vaccine Delivery against Melanoma.
    Wakabayashi R; Sakuragi M; Kozaka S; Tahara Y; Kamiya N; Goto M
    Mol Pharm; 2018 Mar; 15(3):955-961. PubMed ID: 29397746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
    An M; Liu H
    Small; 2017 Jul; 13(26):. PubMed ID: 28544329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen.
    Cole G; Ali AA; McErlean E; Mulholland EJ; Short A; McCrudden CM; McCaffrey J; Robson T; Kett VL; Coulter JA; Dunne NJ; Donnelly RF; McCarthy HO
    Acta Biomater; 2019 Sep; 96():480-490. PubMed ID: 31299353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.
    Zhao JH; Zhang QB; Liu B; Piao XH; Yan YL; Hu XG; Zhou K; Zhang YT; Feng NP
    Int J Nanomedicine; 2017; 12():4763-4772. PubMed ID: 28740383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
    Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
    Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
    Kass E; Panicali DL; Mazzara G; Schlom J; Greiner JW
    Cancer Res; 2001 Jan; 61(1):206-14. PubMed ID: 11196163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routing dependent immune responses after experimental R848-adjuvated vaccination.
    van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F
    Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailoring polymeric hybrid micelles with lymph node targeting ability to improve the potency of cancer vaccines.
    Zeng Q; Li H; Jiang H; Yu J; Wang Y; Ke H; Gong T; Zhang Z; Sun X
    Biomaterials; 2017 Apr; 122():105-113. PubMed ID: 28110170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity.
    Kim SY; Noh YW; Kang TH; Kim JE; Kim S; Um SH; Oh DB; Park YM; Lim YT
    Biomaterials; 2017 Jun; 130():56-66. PubMed ID: 28364631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A surface charge dependent enhanced Th1 antigen-specific immune response in lymph nodes by transfersome-based nanovaccine-loaded dissolving microneedle-assisted transdermal immunization.
    Wu X; Li Y; Chen X; Zhou Z; Pang J; Luo X; Kong M
    J Mater Chem B; 2019 Aug; 7(31):4854-4866. PubMed ID: 31389952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design.
    Chen MC; Lai KY; Ling MH; Lin CW
    Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine.
    Kim NW; Lee MS; Kim KR; Lee JE; Lee K; Park JS; Matsumoto Y; Jo DG; Lee H; Lee DS; Jeong JH
    J Control Release; 2014 Apr; 179():11-7. PubMed ID: 24462900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.
    Zaric M; Lyubomska O; Touzelet O; Poux C; Al-Zahrani S; Fay F; Wallace L; Terhorst D; Malissen B; Henri S; Power UF; Scott CJ; Donnelly RF; Kissenpfennig A
    ACS Nano; 2013 Mar; 7(3):2042-55. PubMed ID: 23373658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly potent intradermal vaccination by an array of dissolving microneedle polypeptide cocktails for cancer immunotherapy.
    Duong HTT; Yin Y; Thambi T; Kim BS; Jeong JH; Lee DS
    J Mater Chem B; 2020 Feb; 8(6):1171-1181. PubMed ID: 31957761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fast-dissolving microneedle array loaded with chitosan nanoparticles to evoke systemic immune responses in mice.
    Li Z; He Y; Deng L; Zhang ZR; Lin Y
    J Mater Chem B; 2020 Jan; 8(2):216-225. PubMed ID: 31803892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.